{"count": 10, "results": [{"_id": "39342648", "pmid": 39342648, "title": "Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment.", "journal": "ACS Nano", "authors": ["Mohaghegh N", "Ahari A", "Buttles C", "Davani S", "Hoang H", "Huang Q", "Huang Y", "Hosseinpour B", "Abbasgholizadeh R", "Cottingham AL", "Farhadi N", "Akbari M", "Kang H", "Khademhosseini A", "Jucaud V", "Pearson RM", "Hassani Najafabadi A"], "date": "2024-09-29T00:00:00Z", "doi": "10.1021/acsnano.4c10742", "meta_date_publication": "2024 Sep 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50245.504, "text_hl": "Sim-NP administration led to the controlled release of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Sim@@@ within AT, directly impacting MPhi activity and inducing AT browning while inducing @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@. ", "citations": {"NLM": "Mohaghegh N, Ahari A, Buttles C, Davani S, Hoang H, Huang Q, Huang Y, Hosseinpour B, Abbasgholizadeh R, Cottingham AL, Farhadi N, Akbari M, Kang H, Khademhosseini A, Jucaud V, Pearson RM, Hassani Najafabadi A. Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment. ACS Nano. 2024 Sep 29;():. PMID: 39342648", "BibTeX": "@article{39342648, title={Simvastatin-Loaded Polymeric Nanoparticles: Targeting Inflammatory Macrophages for Local Adipose Tissue Browning in Obesity Treatment.}, author={Mohaghegh N and Ahari A and Buttles C and Davani S and Hoang H and Huang Q and Huang Y and Hosseinpour B and Abbasgholizadeh R and Cottingham AL and Farhadi N and Akbari M and Kang H and Khademhosseini A and Jucaud V and Pearson RM and Hassani Najafabadi A}, journal={ACS Nano}}"}}, {"_id": "38278349", "pmid": 38278349, "title": "Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.", "journal": "Life Sci", "authors": ["Hasan IH", "Shaheen SY", "Alhusaini AM", "Mahmoud AM"], "date": "2024-03-01T00:00:00Z", "doi": "10.1016/j.lfs.2024.122445", "meta_date_publication": "2024 Mar 1", "meta_volume": "340", "meta_issue": "", "meta_pages": "122445", "score": 50243.914, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ effectively ameliorated @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney hypertrophy@@@, body @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@, and @DISEASE_Soft_Tissue_Injuries @DISEASE_MESH:D017695 @@@tissue injury and@@@ @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ animals. ", "citations": {"NLM": "Hasan IH, Shaheen SY, Alhusaini AM, Mahmoud AM. Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats. Life Sci. 2024 Mar 1;340():122445. PMID: 38278349", "BibTeX": "@article{38278349, title={Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.}, author={Hasan IH and Shaheen SY and Alhusaini AM and Mahmoud AM}, journal={Life Sci}, volume={340}, pages={122445}}"}}, {"_id": "35216778", "pmid": 35216778, "title": "The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.", "journal": "Mult Scler Relat Disord", "authors": ["Stefanou MI", "Palaiodimou L", "Katsanos AH", "Milionis H", "Kosmidou M", "Lambadiari V", "Halvatsiotis P", "Ferentinos P", "Andreadou E", "Marinos G", "Theodorou A", "Tzartos JS", "Voumvourakis K", "Tsivgoulis G", "Giannopoulos S"], "date": "2022-02-01T00:00:00Z", "doi": "10.1016/j.msard.2021.103395", "meta_date_publication": "2022 Feb", "meta_volume": "58", "meta_issue": "", "meta_pages": "103395", "score": 50231.934, "text_hl": "In @DISEASE_Multiple_Sclerosis_Chronic_Progressive @DISEASE_MESH:D020528 @@@SPMS@@@, stand-alone @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ led to significantly reduced annualized rate of whole-brain @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@volume reduction@@@. ", "citations": {"NLM": "Stefanou MI, Palaiodimou L, Katsanos AH, Milionis H, Kosmidou M, Lambadiari V, Halvatsiotis P, Ferentinos P, Andreadou E, Marinos G, Theodorou A, Tzartos JS, Voumvourakis K, Tsivgoulis G, Giannopoulos S. The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2022 Feb;58():103395. PMID: 35216778", "BibTeX": "@article{35216778, title={The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis.}, author={Stefanou MI and Palaiodimou L and Katsanos AH and Milionis H and Kosmidou M and Lambadiari V and Halvatsiotis P and Ferentinos P and Andreadou E and Marinos G and Theodorou A and Tzartos JS and Voumvourakis K and Tsivgoulis G and Giannopoulos S}, journal={Mult Scler Relat Disord}, volume={58}, pages={103395}}"}}, {"_id": "19205554", "pmid": 19205554, "title": "Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction.", "journal": "Bratisl Lek Listy", "authors": ["Yalcin S", "Köksoy C", "Ergül E", "Demirel E", "Yalcin B"], "date": "2008-01-01T00:00:00Z", "meta_date_publication": "2008", "meta_volume": "109", "meta_issue": "11", "meta_pages": "477-82", "score": 50052.023, "text_hl": "RESULTS: We observed that @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight-loss@@@ observed in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@ were partially treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, but were still different from the control group. ", "citations": {"NLM": "Yalcin S, Köksoy C, Ergül E, Demirel E, Yalcin B. Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction. Bratisl Lek Listy. 2008;109(11):477-82. PMID: 19205554", "BibTeX": "@article{19205554, title={Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction.}, author={Yalcin S and Köksoy C and Ergül E and Demirel E and Yalcin B}, journal={Bratisl Lek Listy}, volume={109}, number={11}, pages={477-82}}"}}, {"_id": "22529483", "pmid": 22529483, "pmcid": "PMC3326920", "title": "A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin", "journal": "Indian J Pharmacol", "authors": ["Gopa B", "Bhatt J", "Hemavathi KG"], "date": "2012-03-01T00:00:00Z", "doi": "10.4103/0253-7613.93857", "meta_date_publication": "2012 Mar", "meta_volume": "44", "meta_issue": "2", "meta_pages": "238-42", "score": 50049.258, "text_hl": "Similarly, treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ produced significant @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@reduction@@@ of TC (P<0.0001), LDL (P<0.0009), @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@TG@@@ and VLDL (P<0.017), and a significant increase in HDL levels (P<0.0001). ", "citations": {"NLM": "Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin Indian J Pharmacol. 2012 Mar;44(2):238-42. PMID: 22529483", "BibTeX": "@article{22529483, title={A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin}, author={Gopa B and Bhatt J and Hemavathi KG}, journal={Indian J Pharmacol}, volume={44}, number={2}, pages={238-42}}"}}, {"_id": "30379218", "pmid": 30379218, "title": "Effects of simvastatin on 5-fluorouracil-induced gastrointestinal mucositis in rats.", "journal": "Rev Col Bras Cir", "authors": ["Medeiros ADC", "Azevedo ÍM", "Lima ML", "Araújo Filho I", "Moreira MD"], "date": "2018-10-18T00:00:00Z", "doi": "10.1590/0100-6991e-20181968", "meta_date_publication": "2018 Oct 18", "meta_volume": "45", "meta_issue": "5", "meta_pages": "e1968", "score": 50047.527, "text_hl": "The @CHEMICAL_Fluorouracil @CHEMICAL_MESH:D005472 @@@5-FU@@@+@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@CHEMICAL_Fluorouracil @CHEMICAL_MESH:D005472 @@@5-FU@@@/SIMV) group was treated with @CHEMICAL_Fluorouracil @CHEMICAL_MESH:D005472 @@@5-FU@@@ (50mg/kg), plus @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (10mg/kg), in the same way. ", "citations": {"NLM": "Medeiros ADC, Azevedo ÍM, Lima ML, Araújo Filho I, Moreira MD. Effects of simvastatin on 5-fluorouracil-induced gastrointestinal mucositis in rats. Rev Col Bras Cir. 2018 Oct 18;45(5):e1968. PMID: 30379218", "BibTeX": "@article{30379218, title={Effects of simvastatin on 5-fluorouracil-induced gastrointestinal mucositis in rats.}, author={Medeiros ADC and Azevedo ÍM and Lima ML and Araújo Filho I and Moreira MD}, journal={Rev Col Bras Cir}, volume={45}, number={5}, pages={e1968}}"}}, {"_id": "25821305", "pmid": 25821305, "pmcid": "PMC4375812", "title": "Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats", "journal": "Indian J Pharmacol", "authors": ["Maheshwari RA", "Balaraman R", "Sailor GU", "Sen DB"], "date": "2015-01-01T00:00:00Z", "doi": "10.4103/0253-7613.150311", "meta_date_publication": "2015 Jan-Feb", "meta_volume": "47", "meta_issue": "1", "meta_pages": "17-21", "score": 50046.844, "text_hl": "DAI score, an indicator of the severity of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@intestinal inflammation@@@, was a significant increase in the @DISEASE_Colitis @DISEASE_MESH:D003092 @@@colitis@@@ control group. In the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@-treated groups, we did not observe bloody stools, stools were better formed, and @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ was lessened. ", "citations": {"NLM": "Maheshwari RA, Balaraman R, Sailor GU, Sen DB. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats Indian J Pharmacol. 2015 Jan-Feb;47(1):17-21. PMID: 25821305", "BibTeX": "@article{25821305, title={Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats}, author={Maheshwari RA and Balaraman R and Sailor GU and Sen DB}, journal={Indian J Pharmacol}, volume={47}, number={1}, pages={17-21}}"}}, {"_id": "29860221", "pmid": 29860221, "title": "Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.", "journal": "Biomed Pharmacother", "authors": ["Al-Rasheed NM", "Al-Rasheed NM", "Bassiouni YA", "Hasan IH", "Al-Amin MA", "Al-Ajmi HN", "Mahmoud AM"], "date": "2018-09-01T00:00:00Z", "doi": "10.1016/j.biopha.2018.05.130", "meta_date_publication": "2018 Sep", "meta_volume": "105", "meta_issue": "", "meta_pages": "290-298", "score": 50045.285, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ was induced by a single intraperitoneal injection of 55 mg/kg body weight @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@ (@CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@) and both control and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@ received 10 mg/kg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ for 90 days. Treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ diminished the body @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@, @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ and, serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@, @CHEMICAL_Urea @CHEMICAL_MESH:D014508 @@@urea@@@ and @CHEMICAL_Uric_Acid @CHEMICAL_MESH:D014527 @@@uric acid@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Al-Rasheed NM, Al-Rasheed NM, Bassiouni YA, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mahmoud AM. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes. Biomed Pharmacother. 2018 Sep;105():290-298. PMID: 29860221", "BibTeX": "@article{29860221, title={Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.}, author={Al-Rasheed NM and Al-Rasheed NM and Bassiouni YA and Hasan IH and Al-Amin MA and Al-Ajmi HN and Mahmoud AM}, journal={Biomed Pharmacother}, volume={105}, pages={290-298}}"}}, {"_id": "26544069", "pmid": 26544069, "title": "Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.", "journal": "Cell Physiol Biochem", "authors": ["Jiang X", "Yuan L", "Li P", "Wang J", "Wang P", "Zhang L", "Sun B", "Sun W"], "date": "2015-01-01T00:00:00Z", "doi": "10.1159/000438536", "meta_date_publication": "2015", "meta_volume": "37", "meta_issue": "5", "meta_pages": "1712-24", "score": 50042.88, "text_hl": "Cigarette smoke exposure resulted in significant reduction in animal body weight, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ significantly prevented smoke-induced @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@. ", "citations": {"NLM": "Jiang X, Yuan L, Li P, Wang J, Wang P, Zhang L, Sun B, Sun W. Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension. Cell Physiol Biochem. 2015;37(5):1712-24. PMID: 26544069", "BibTeX": "@article{26544069, title={Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.}, author={Jiang X and Yuan L and Li P and Wang J and Wang P and Zhang L and Sun B and Sun W}, journal={Cell Physiol Biochem}, volume={37}, number={5}, pages={1712-24}}"}}, {"_id": "14969507", "pmid": 14969507, "title": "A systematic review of the clinical effectiveness of orlistat used for the management of obesity.", "journal": "Obes Rev", "authors": ["O'Meara S", "Riemsma R", "Shirran L", "Mather L", "ter Riet G"], "date": "2004-02-01T00:00:00Z", "doi": "10.1111/j.1467-789x.2004.00125.x", "meta_date_publication": "2004 Feb", "meta_volume": "5", "meta_issue": "1", "meta_pages": "51-68", "score": 50040.28, "text_hl": "When @CHEMICAL_Orlistat @CHEMICAL_MESH:D000077403 @@@orlistat@@@ was added to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, this proved to be more effective for @<m>DISEASE_Weight_Loss</m> @DISEASE_MESH:D015431 @@@weight loss@@@ than either drug used individually. ", "citations": {"NLM": "O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. A systematic review of the clinical effectiveness of orlistat used for the management of obesity. Obes Rev. 2004 Feb;5(1):51-68. PMID: 14969507", "BibTeX": "@article{14969507, title={A systematic review of the clinical effectiveness of orlistat used for the management of obesity.}, author={O'Meara S and Riemsma R and Shirran L and Mather L and ter Riet G}, journal={Obes Rev}, volume={5}, number={1}, pages={51-68}}"}}]}